TORONTO, Ontario and CAMBRIDGE, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today its participation in the H.C. Wainwright… Read More..

Virtual Conference on January 10-13, 2022 BASKING RIDGE, NJ, Jan. 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that John Koconis, Chairman and… Read More..

DALLAS, January 05, 2022--(BUSINESS WIRE)--Blackboxstocks Inc. (NASDAQ: BLBX) ("Blackbox"), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, today released a shareholder update. Dear Shareholders, As we close the books on 2021, and the new year is upon us,… Read More..